HYDRALYTE_1170x120

the Patient Right to Know Drug Prices Act

Health leaders visit community pharmacy owners to promote “gag clause” ban

Health leaders visit community pharmacy owners to promote “gag clause” ban

PITTSBURGH  – U.S. Department of Health and Human Services secretary Alex Azar and Paul Mango, chief principal deputy administrator and chief of staff in the Centers for Medicare and Medicaid Services’ Office of the Administrator, today visited Spartan Pharmacy in Pittsburgh as part of ongoing efforts to highlight President Trump’s signing into law legislation to ban

NCPA leaders attend White House signing of “gag clause” ban

NCPA leaders attend White House signing of “gag clause” ban

WASHINGTON— Four National Community Pharmacists Association leaders joined President Trump at the White House today as he signed legislation prohibiting so-called pharmacy “gag clauses” that may result in patients being charged inflated prices for their medications. Attending were newly-installed president Bill Osborn, owner of Osborn Drugs in Miami, Okla.; NCPA board members Michele M. Belcher, owner of Grants

PCMA supports legislation for lowest prices for prescription drugs

PCMA supports legislation for lowest prices for prescription drugs

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on S. 2554, the Patient Right to Know Drug Prices Act, scheduled to be marked up tomorrow in the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP): “PCMA strongly supports S. 2554, legislation that will ensure America’s